| Index | — | P/E | 31.30 | EPS (ttm) | 1.32 | Insider Own | 18.47% | Shs Outstand | 34.38M | Perf Week | -31.03% |
| Market Cap | 1.42B | Forward P/E | 25.54 | EPS next Y | 1.62 | Insider Trans | -25.87% | Shs Float | 32.72M | Perf Month | -41.03% |
| Enterprise Value | 1.18B | PEG | 115.93 | EPS next Q | 0.17 | Short Float | 13.82% | Perf Quarter | -41.15% | ||
| Income | 46.00M | P/S | 4.48 | EPS this Y | 40.57% | Short Ratio | 3.29 | Perf Half Y | -9.62% | ||
| Sales | 317.00M | P/B | 8.88 | EPS next Y | 31.16% | ROA | 13.03% | Short Interest | 4.52M | Perf YTD | -18.90% |
| Book/sh | 4.65 | P/C | 5.68 | EPS next 5Y | 0.27% | ROE | 37.78% | 52W High | 125.14 -66.98% | Perf Year | -44.63% |
| Cash/sh | 7.27 | P/FCF | 6.49 | EPS past 3/5Y | — 107.18% | ROIC | 24.51% | 52W Low | 34.23 20.71% | Perf 3Y | 494.53% |
| Dividend Est. | — | EV/EBITDA | 17.17 | Sales past 3/5Y | 47.21% 34.15% | Gross Margin | 42.63% | Volatility | 8.38% 6.58% | Perf 5Y | 305.10% |
| Dividend TTM | — | EV/Sales | 3.74 | EPS Y/Y TTM | 6.45% | Oper. Margin | 16.97% | ATR (14) | 4.69 | Perf 10Y | 1586.53% |
| Dividend Ex-Date | — | Quick Ratio | 1.73 | Sales Y/Y TTM | 39.65% | Profit Margin | 14.66% | RSI (14) | 31.05 | Recom | 2.17 |
| Dividend Gr. 3/5Y | — | Current Ratio | 1.73 | EPS Q/Q | 105.00% | SMA20 | -25.28% | Beta | 3.05 | Target Price | 120.00 |
| Payout | 0.00% | Debt/Eq | 0.09 | Sales Q/Q | 58.62% | SMA50 | -29.17% | Rel Volume | 0.87 | Prev Close | 43.81 |
| Employees | 10,064 | LT Debt/Eq | 0.07 | Earnings | Nov 05 | SMA200 | -32.61% | Avg Volume | 1.57M | Price | 41.32 |
| IPO Date | Aug 10, 1993 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 92.49% 6.76% | Net Debt/EBITDA | -3.42 | Volume | 1,368,575 | Change | -5.68% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Jun-04-26 | Reiterated | Wedbush | Outperform | $90 → $120 |
| Jan-05-26 | Upgrade | BWS Financial | Buy → Top Pick | |
| Oct-15-25 | Reiterated | Wedbush | Outperform | $48 → $90 |
| Dec-19-24 | Initiated | Wedbush | Outperform | $48 |
| Sep-17-24 | Initiated | Craig-Hallum | $23 | |
| Jul-26-13 | Downgrade | Noble Capital Markets | Buy → Hold |
Innodata Inc. is a global enterprise specializing in data engineering, with operations spanning the United States, the United Kingdom, the Netherlands, Canada, and other international locations. The firm conducts its business across three distinct divisions: Digital Data Solutions (DDS), Synodex, and Agility. Its Digital Data Solutions (DDS) division furnishes clients with AI-powered software platforms and outsourced services. These offerings cater to businesses needing data for the instruction of artificial intelligence (AI) and machine learning (ML) algorithms. DDS also delivers AI-driven digital transformation strategies, assisting organizations in leveraging AI/ML to extract critical insights from textual information. Furthermore, DDS provides a comprehensive suite of data engineering support functions, encompassing activities such as data annotation, transformation, curation, hygiene, consolidation, compliance, and master data management. The Synodex segment supplies an industry-specific platform designed to convert medical records into actionable digital data. This conversion utilizes either Synodex's proprietary data models or models provided by its clients. Lastly, the Agility division delivers a specialized platform for marketing and public relations experts. This platform enables them to identify and disseminate information to journalists and social media figures, alongside monitoring and dissecting content from global news outlets—including print, online, radio, and television—as well as various social media platforms. Innodata caters to a diverse clientele across sectors such as banking, insurance, financial services, technology, digital retail, and information/media. Its services are delivered by a dedicated team comprising professional staff, senior leadership, and direct sales representatives. The corporation, initially named Innodata Isogen, Inc., adopted its current moniker, Innodata Inc., in June 2012. Established in 1988, its principal office is situated in Ridgefield Park, New Jersey.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 317 | 252 | 170 | 87 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 183 | 152 | 104 | 55 | — | — | — | — | — | |
| Gross Profit | 135 | 100 | 67 | 32 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 81 | 60 | 43 | 31 | — | — | — | — | — | |
| Research and Development | 1 | 0 | 4 | 0 | — | — | — | — | — | |
| Other Operating Expense | 0 | 0 | -4 | 0 | — | — | — | — | — | |
| Operating Income | 54 | 40 | 24 | 1 | — | — | — | — | — | |
| Interest Expense | 2 | 0 | 0 | 0 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 5 | 1 | 0 | -1 | — | — | — | — | — | |
| Net Income Before Taxes | 58 | 41 | 24 | 0 | — | — | — | — | — | |
| Income Taxes | 12 | 9 | -4 | 1 | — | — | — | — | — | |
| Consolidated Net Income | 46 | 32 | 29 | -1 | — | — | — | — | — | |
| Net Income From Continuing Operations | 46 | 32 | 29 | -1 | — | — | — | — | — | |
| Net Income | 46 | 32 | 29 | -1 | — | — | — | — | — | |
| EPS (Recurring) | 1.43 | 1.01 | 0.98 | -0.03 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 1.43 | 1.01 | 0.98 | -0.03 | — | — | — | — | — | |
| EPS (Diluted) | 1.32 | 0.92 | 0.89 | -0.03 | — | — | — | — | — | |
| EBITDA | 69 | 48 | 30 | 5 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 31.30 | 55.38 | 44.40 | — | — | — | — | — | — | |
| Price To Sales Ratio | 4.30 | 6.47 | 6.74 | 2.62 | — | — | — | — | — | |
| Gross Margin | 42.59 | 39.68 | 39.41 | 36.78 | — | — | — | — | — | |
| Operating Margin | 17.03 | 15.87 | 14.12 | 1.15 | — | — | — | — | — | |
| Net Margin | 14.51 | 12.70 | 17.06 | -1.15 | — | — | — | — | — | |
| Shares Outstanding | 33 | 32 | 29 | 28 | — | — | — | — | — | |
| Market Capitalization | 1,364 | 1,630 | 1,146 | 228 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| FORLENZA LOUISE C | Director | Sep 14 '26 | Option Exercise | 1.42 | 10,000 | 14,200 | 15,424 | Sep 15 |
| FORLENZA LOUISE C | Director | Sep 14 '26 | Sale | 53.54 | 10,000 | 535,400 | 5,424 | Sep 15 |
| FORLENZA LOUISE C | Director | Sep 04 '26 | Sale | 55.01 | 10,000 | 550,100 | 5,424 | Sep 04 |
| FORLENZA LOUISE C | Director | Sep 04 '26 | Option Exercise | 1.38 | 10,000 | 13,840 | 15,424 | Sep 04 |
| ABUHOFF JACK | CEO | Jun 16 '26 | Sale | 110.20 | 200,000 | 22,040,948 | 1,340,456 | Jun 16 |
| ABUHOFF JACK | CEO | Jun 16 '26 | Option Exercise | 1.96 | 200,000 | 391,092 | 1,540,456 | Jun 16 |
| ABUHOFF JACK | CEO | Jun 15 '26 | Sale | 105.70 | 94,059 | 9,942,343 | 1,340,456 | Jun 16 |
| ABUHOFF JACK | CEO | Jun 15 '26 | Option Exercise | 3.41 | 94,059 | 320,741 | 1,434,515 | Jun 16 |
| MISHRA ASHOK | EVP and COO | Jun 02 '26 | Option Exercise | 43.01 | 26,666 | 1,146,905 | 121,845 | Jun 03 |
| MISHRA ASHOK | EVP and COO | Jun 02 '26 | Sale | 114.34 | 38,666 | 4,421,108 | 83,179 | Jun 03 |
| Espineli Marissa B | Interim CFO | May 29 '26 | Option Exercise | 19.52 | 19,667 | 383,864 | 47,681 | Jun 01 |
| Espineli Marissa B | Interim CFO | May 29 '26 | Sale | 105.88 | 19,667 | 2,082,436 | 28,014 | Jun 01 |
| ABUHOFF JACK | CEO | May 29 '26 | Option Exercise | 4.99 | 105,586 | 526,874 | 1,446,042 | Jun 01 |
| ABUHOFF JACK | CEO | May 29 '26 | Sale | 103.50 | 105,586 | 10,928,426 | 1,340,456 | Jun 01 |
| ABUHOFF JACK | CEO | May 22 '26 | Sale | 100.39 | 38,056 | 3,820,591 | 1,340,456 | May 26 |